These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2892508)

  • 21. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to Vibrio cholerae somatic and enterotoxin antigens in human colostrum.
    Majumdar AS; Ghosh AK; Pal SC; Ghose AC
    Indian J Med Res; 1982 Apr; 75():474-9. PubMed ID: 7106887
    [No Abstract]   [Full Text] [Related]  

  • 23. Agglutinogens and fimbriae of Bordetella pertussis.
    Ashworth LA; Robinson A; Funnell S; Gorringe AR; Irons LI; Seabrook RN
    Tokai J Exp Clin Med; 1988; 13 Suppl():203-10. PubMed ID: 2908520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
    Blanco LP; DiRita VJ
    Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin.
    Harari I; Donohue-Rolfe A; Keusch GT; Arnon R
    Ann Sclavo Collana Monogr; 1986; 3(1-2):125-30. PubMed ID: 3322336
    [No Abstract]   [Full Text] [Related]  

  • 26. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
    Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
    Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nonselective mechanism of antibody-induced stable antigenic variability of microorganisms. III. Suggested mechanism of variability of certain microorganisms].
    Kuznetsov EA; Oleĭnik II
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Feb; (2):78-82. PubMed ID: 6178238
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of epitopes of the receptor binding subunit of cholera toxin by synthetic peptide and CBIB approaches.
    Kazemi M; Finkelstein RA
    Adv Exp Med Biol; 1991; 303():249-54. PubMed ID: 1725236
    [No Abstract]   [Full Text] [Related]  

  • 30. Animal models for immunoglobulin A secretion.
    Keren DF; Suckow MA
    Methods Enzymol; 1994; 235():140-55. PubMed ID: 8057892
    [No Abstract]   [Full Text] [Related]  

  • 31. Peptide sharing between Bordetella pertussis proteome and human sudden death proteins: a hypothesis for a causal link.
    Capone G; Kanduc D
    Future Microbiol; 2013 Aug; 8(8):1039-48. PubMed ID: 23902149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A toxoid prepared from cholera toxin by iodination.
    Heneine IF; Lahmann WM; Rocha OA
    Braz J Med Biol Res; 1992; 25(9):913-7. PubMed ID: 1342838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular engineering of cholera toxin.
    Burnette WN; Kaslow HR; Moss J
    Adv Exp Med Biol; 1995; 371B():1513-8. PubMed ID: 7502847
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholera enterotoxin (choleragen).
    Finkelstein RA; Dorner F
    Pharmacol Ther; 1985; 27(1):37-47. PubMed ID: 3889940
    [No Abstract]   [Full Text] [Related]  

  • 35. Antigens of Bordetella pertussis. II. Purification of heat-labile toxin.
    BANERJEA A; MUNOZ J
    J Bacteriol; 1962 Aug; 84(2):269-74. PubMed ID: 13864610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of antisera to thermostable direct hemolysin and cholera enterotoxin to prevent accumulation of fluid caused by Vibrio parahaemolyticus.
    Honda T; Takeda Y; Miwatani T; Nakahara N
    J Infect Dis; 1983 Apr; 147(4):779. PubMed ID: 6842011
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbial interference with host defence mechanisms.
    Smith H
    Monogr Allergy; 1975; 9():13-38. PubMed ID: 235083
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation of vaccines by the action of glutaraldehyde on toxins, bacteria, viruses, allergens, and cells.
    Relyveld EH; Ben-Efraim S
    Methods Enzymol; 1983; 93():24-60. PubMed ID: 6306393
    [No Abstract]   [Full Text] [Related]  

  • 39. [Purification of the agglutinogen, the toxin, and the infection-preventing antigen, cell-body constituents of Bordetella pertussis].
    KASUGA T; NAKASE Y
    Nisshin Igaku Jpn J Med Prog; 1962 Apr; 49():283-6. PubMed ID: 14454203
    [No Abstract]   [Full Text] [Related]  

  • 40. Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies.
    Presentini R; Perin F; Ancilli G; Rappuoli R; Bartoloni A; Lozzi L; Neri P; Antoni G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):283-8. PubMed ID: 2892508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.